RESUMO
OBJECTIVE: Des-gamma-carboxy prothrombin (DCP), also called protein induced by vitamin K absence or antagonist II (PIVKA-II), is a tumor marker complementary to AFP for the diagnosis of hepatocellular carcinoma (HCC). Currently available immunoassays for DCP are not sensitive enough to detect HCC at an early stage. Recently, two new immunoassays with enhanced sensitivity were developed. The aim of this study was to assess the diagnostic values of the new methods in patients with small-sized HCC. METHODS: Coded serum samples obtained from 36 patients with small-sized and single-nodular HCC (< or = 3 cm in diameter) and 49 patients with posthepatitic cirrhosis not carrying HCC were analyzed. DCP levels were determined in three different ways: 1) conventional EIA; 2) a new immunoassay using the electrochemiluminescence (ECLIA) detection system; and 3) a new immunoradiometric assay (IRMA). Lectin-reactive profiles of AFP (AFP-L3) were also determined. RESULTS: In 36 patients with small-sized HCC, the rates of abnormal values obtained by the conventional, ECLIA, and IRMA methods were 2.7%, 27.8%, and 16.7%, respectively. An ROC analysis of the two new methods (ECLIA vs IRMA) revealed a better performance by the ECLIA method (p < 0.05). The true positive rate of AFP-L3 was 22.2%, whereas a combination assay of ECLIA for DCP and AFP-L3 resulted in a 41.7% sensitivity with a specificity of 90%. CONCLUSIONS: Compared with the conventional method, the sensitivity in detecting small-sized HCC was increased in the two new DCP immunoassays (ECLIA and IRMA). The overall performance as evaluated by an ROC analysis was significantly better in ECLIA than in IRMA.
Assuntos
Biomarcadores Tumorais/sangue , Biomarcadores , Carcinoma Hepatocelular/diagnóstico , Imunoensaio , Neoplasias Hepáticas/diagnóstico , Precursores de Proteínas/análise , Protrombina/análise , Carcinoma Hepatocelular/patologia , Feminino , Humanos , Imunoensaio/métodos , Ensaio Imunorradiométrico , Neoplasias Hepáticas/patologia , Medições Luminescentes , Masculino , Valor Preditivo dos Testes , Curva ROC , Sensibilidade e EspecificidadeRESUMO
Thymidylate synthase and thymidine kinase are key enzymes involved in the de novo and salvage pathways for pyrimidine nucleotide synthesis, respectively. Thymidylate synthase is inhibited by 5-fluorodeoxyuridine monophosphate, forming an inactive ternary complex with intracellular folate. We investigated the effects of 1-(2-tetrahydrofuryl)-5-FU plus uracil (UFT) with or without leucovorin on 1,2-dimethylhydrazine-induced rat colorectal carcinomas. Thirty-week administration of UFT with or without leucovorin markedly suppressed both colorectal carcinogenesis and tumor growth, resulted in the increase of thymidylate synthase inhibition and the decrease of thymidine kinase activity in the tumor cells. These results indicate that the combination of UFT with leucovorin could be useful in the development of pre- and post-operative adjuvant chemotherapy programs.
Assuntos
Antimetabólitos Antineoplásicos/uso terapêutico , Neoplasias Colorretais/tratamento farmacológico , Leucovorina/uso terapêutico , Tegafur/uso terapêutico , 1,2-Dimetilidrazina , Animais , Antimetabólitos Antineoplásicos/administração & dosagem , Antimetabólitos Antineoplásicos/sangue , Carcinógenos , Neoplasias Colorretais/induzido quimicamente , Neoplasias Colorretais/enzimologia , Fluordesoxiuridilato/metabolismo , Leucovorina/administração & dosagem , Masculino , Ratos , Tegafur/administração & dosagem , Tegafur/sangue , Timidina Quinase/metabolismo , Timidilato Sintase/metabolismoRESUMO
Thymidylate synthase, which is a key enzyme involved in the de novo pathway for pyrimidine nucleotide synthesis, is inhibited by 5-fluorodeoxyuridine monophosphate, forming an inactive ternary complex with intracellular folate. We investigated the effect of a 5-fluorouracil derivative (UFT) with or without low dose leucovorin on the number of 5-fluorodeoxyuridine monophosphate binding sites, thymidine kinase activity and intracellular folate concentration in 1,2-dimethylhydrazine-induced rat colorectal carcinomas. A 10-day administration of UFT with or without leucovorin enhanced the thymidine kinase activity and the number of 5-fluorodeoxyuridine monophosphate binding sites, with an increase of thymidylate synthase mRNA expression. Thymidylate synthase inhibition was slightly increased as the intracellular folate concentration increased. These results indicate that thymidylate synthase inhibition increases when the intracellular folate is exogenously supplemented and maintained at an adequate concentration.
Assuntos
Neoplasias Colorretais/tratamento farmacológico , Fluoruracila/uso terapêutico , Leucovorina/uso terapêutico , 1,2-Dimetilidrazina , Animais , Sequência de Bases , Peso Corporal , Carcinógenos , Neoplasias Colorretais/induzido quimicamente , Neoplasias Colorretais/enzimologia , Primers do DNA , Fluoruracila/administração & dosagem , Fluoruracila/sangue , Leucovorina/administração & dosagem , Tamanho do Órgão , RNA Mensageiro/genética , Ratos , Timidina Quinase/genética , Timidina Quinase/metabolismo , Timidilato Sintase/genética , Timidilato Sintase/metabolismoAssuntos
Testes de Química Clínica/métodos , Eletrólitos/sangue , Ferro/sangue , Fósforo/sangue , Desequilíbrio Ácido-Base/diagnóstico , Acidose/diagnóstico , Alcalose/diagnóstico , Amônia/sangue , Bicarbonatos/sangue , Biomarcadores/sangue , Dióxido de Carbono/sangue , Doenças Hematológicas/diagnóstico , HumanosRESUMO
Sho-saiko-to (SST) and Juzen-taiho-to (JTT), Japanese modified Chinese herbal prescriptions, suppressed the activities of thymidylate synthetase and thymidine kinase involved in de novo and salvage pathways for pyrimidine nucleotide synthesis, respectively, in mammary tumors of SHN mice with the reduction of serum prolactin level. These results indicate that SST and JTT may have the antitumor effects on mammary tumors.
Assuntos
Antineoplásicos Fitogênicos/farmacologia , DNA de Neoplasias/biossíntese , Medicamentos de Ervas Chinesas/farmacologia , Neoplasias Mamárias Experimentais/enzimologia , Animais , Peso Corporal/efeitos dos fármacos , Peso Corporal/fisiologia , Estro/efeitos dos fármacos , Feminino , Neoplasias Mamárias Experimentais/patologia , Camundongos , Camundongos Endogâmicos , Tamanho do Órgão/efeitos dos fármacos , Tamanho do Órgão/fisiologia , Prolactina/sangue , Timidina Quinase/metabolismo , Timidilato Sintase/metabolismoRESUMO
Sho-saiko-to (SST), Keishi-bukuryo-gan (KBG), and Shakuyaku-kanzo-to (SKT) are Japanese modified traditional Chinese herbal medicines (Kampo medicines) consisting of 7, 5, and 2 medical plants, respectively. It is known that the hyperplastic alveolar nodule (HAN) is a representative preneoplastic state in the mammary glands of mice. We examined the effects of SST, KBG, and SKT on the formation and growth of HAN in a high-mammary-tumor strain of SHN virgin mice. Oral administration of SST for 60 days beginning at 90 days of age reduced the number and area of HAN and mammary thymidylate synthetase activity with a reduction of serum prolactin level. There was little difference between the other experimental groups and the control in the formation and growth of HAN and the enzyme activities. These results indicate that SST may have a preventive effect on malignant mammary transformations.
Assuntos
Medicamentos de Ervas Chinesas/farmacologia , Neoplasias Mamárias Experimentais/tratamento farmacológico , Lesões Pré-Cancerosas/tratamento farmacológico , Animais , Feminino , Hiperplasia , Glândulas Mamárias Animais/enzimologia , Glândulas Mamárias Animais/patologia , Neoplasias Mamárias Experimentais/enzimologia , Camundongos , Lesões Pré-Cancerosas/enzimologia , Prolactina/sangue , Timidina Quinase/sangue , Timidilato Sintase/sangueRESUMO
Sho-Saiko-To (SST) is a modified Japanese traditional Chinese herbal medicine containing seven medical plants: Bupleuri radix, Pinelliae tuber, Suxtallariae radix, Zizyphi fructus, Ginseng radix, Glycyrrhizae radix, and Zingiberis recens rhizoma. This preparation has been used in the treatment of some inflammatory diseases of the respiratory system and chronic hepatitis. In the present study, the effects of SST were investigated on the activities of DNA-synthesizing enzymes in 1,2-dimethylhydrazine (DMH)-induced colonic carcinomas in rats. Six-week administration of SST prevented nearly 100% of the body weight loss and the final number of the colonic carcinomas compared to those in the rats treated with DMH alone, and suppressed the enhanced activities of thymidylate synthetase (TS) and thymidine kinase (TK) which were involved in the de novo and salvage pathways of pyrimidine synthesis, respectively, in DMH-induced colonic carcinomas. These results indicate that SST may show directly and/or indirectly inhibitory effects on the development of colonic carcinomas.
Assuntos
Antineoplásicos Fitogênicos/farmacologia , Neoplasias do Colo/tratamento farmacológico , DNA/biossíntese , Medicamentos de Ervas Chinesas/farmacologia , Timidina Quinase/antagonistas & inibidores , Timidilato Sintase/antagonistas & inibidores , 1,2-Dimetilidrazina , Animais , Neoplasias do Colo/induzido quimicamente , Neoplasias do Colo/enzimologia , Neoplasias do Colo/genética , Dimetilidrazinas , Masculino , RatosRESUMO
The effects of traditional Chinese herbal remedies, Shakuyaku-kanzo-to (SKT) and Hachimijiou-gan (HJG), on the spontaneous development of uterine adenomyosis and mammary hyperplastic alveolar nodules (HAN) were examined in an experimental animal model using SHN strain of mice. Female mice were provided with the chow containing 1% of SKT or HJG during 25-150 days of age. At 150 days of age, SKT treatment showed significantly lower incidence of adenomyosis, and HJG treatment resulted in a significantly lower incidence of HAN when compared to a control chow containing no medicines. Long-term exposure to these herbal medicines affected little serum prolactin (PRL) level, estrous cycle, food intake and body growth. Thus, the present mouse data suggest that the oral administration of these herbal medicines is a useful tool for the treatment of uterine adenomyosis or mammary disorder such as cystic mastitis.
Assuntos
Adenomioma/prevenção & controle , Medicamentos de Ervas Chinesas/uso terapêutico , Glândulas Mamárias Animais/patologia , Neoplasias Mamárias Animais/prevenção & controle , Neoplasias Uterinas/prevenção & controle , Adenomioma/patologia , Animais , Peso Corporal/efeitos dos fármacos , Combinação de Medicamentos , Medicamentos de Ervas Chinesas/farmacologia , Ingestão de Alimentos/efeitos dos fármacos , Estro/efeitos dos fármacos , Feminino , Glycyrrhiza , Hiperplasia/prevenção & controle , Camundongos , Paeonia , Prolactina/sangue , Neoplasias Uterinas/patologiaRESUMO
Juzen-taiho-to (JTT; [Shi-quan-da-bu-tang], a Japanese modified Chinese herbal prescription) in combination with an anticancer drug UFT (5-fluorouracil derivative) prevented the body weight loss and the induction of the colonic cancer in rats treated with a chemical carcinogen 1,2-dimethylhydrazine (DMH), and suppressed markedly the activity of thymidylate synthetase (TS) involved in the de novo pathway of pyrimidine synthesis in colonic cancer induced by DMH.
Assuntos
Adenocarcinoma/tratamento farmacológico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias do Colo/tratamento farmacológico , Medicamentos de Ervas Chinesas/administração & dosagem , Fluoruracila/administração & dosagem , Timidilato Sintase/efeitos dos fármacos , Adenocarcinoma/enzimologia , Adenocarcinoma/patologia , Animais , Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Protocolos de Quimioterapia Combinada Antineoplásica/farmacologia , Neoplasias do Colo/enzimologia , Neoplasias do Colo/patologia , Avaliação Pré-Clínica de Medicamentos , Estadiamento de Neoplasias , Ratos , Timidina Quinase/efeitos dos fármacos , Redução de Peso/efeitos dos fármacosRESUMO
It has been known that a high incidence of adenocarcinoma in distal colon can be induced by s.c. injection of 1, 2-dimethylhydrazine (DMH) into rats at weekly intervals. We investigated effects of radiofrequency hyperthermia (RF-HT) in combination with anti-cancer drug UFT (a combination of tegafur and uracil) on activities of DNA-synthesizing enzymes, using colon carcinomas induced by DMH treatment in rats. 1) Thymidylate synthetase (TS), DNA-synthesizing enzyme in de novo pathway of pyrimidine metabolism, increased to approximately 7-fold that of normal control colon in DMH-induced colon carcinomas in activity, but was markedly reduced to 48% of that in the carcinomas by administration of UFT. 2) Thymidine kinase (TK) in salvage pathway increased to approximately 8-fold that of the control in the carcinomas in activity, but was markedly reduced to 25% of that in the carcinomas by RF-HT treatment. 3) The TK-isozyme, that was thought to be a fetal type in the intracellularly cytoplasmic fraction and closely involved in rapid DNA replication, increased to approximately 24-fold that of the control in the carcinomas in activity, but was reduced to the nearly same level as that of the control by RF-HT treatment. This isozyme was labile in thermostability and easy to be inactivated in low pH. 4) The activities of TS and TK in the carcinomas were extremely suppressed by UFT administration in combination with RF-HT treatment. These results indicate that hyperthermochemotherapy with UFT may serve as an available treatment for colon carcinomas.
Assuntos
Adenocarcinoma/terapia , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias do Colo/terapia , Hipertermia Induzida , Timidina Quinase/metabolismo , Timidilato Sintase/metabolismo , 1,2-Dimetilidrazina , Adenocarcinoma/enzimologia , Animais , Neoplasias do Colo/enzimologia , Terapia Combinada , Dimetilidrazinas , Isoenzimas/metabolismo , Ratos , Ratos Endogâmicos , Tegafur/administração & dosagem , Uracila/administração & dosagemRESUMO
Keishi-bukuryo-gan (TJ-25) is a traditional Chinese herbal remedy containing five components: bark of Cinnamomum cassia, root of Paeonia lactiflora, seed of Prunus persica or P. persiba var. davidiana, carpophores of Poria cocos and root bark of Paeonia suffruticosa. This preparation has been used in the treatment of gynecological disorders such as hypermenorrhea, dysmenorrhea and infertility. In the present study, the effects of TJ-25 on plasma levels of luteinizing hormone (LH), follicle-stimulating hormone (FSH) and estradiol (E2), and on uterine wet weight and thymidine kinase (TK) activity were documented in immature rats. Long-term daily oral administration of TJ-25 (300 mg/kg) for 14 days decreased plasma levels of LH, FSH and E2 by 94%, 67% and 50%, respectively, compared to controls. Uterine wet weight and TK activity were reduced to 65% and 64% that of controls, respectively. Short-term effects of TJ-25 on E2 were also examined. Thirty hours after administration of E2 (1.0 micrograms/kg) alone, uterine wet weight and TK activity were elevated 2.4- and 21-fold, respectively, over controls. However, simultaneous administration of TJ-25 (three consecutive doses, every 12 h) with E2 reduced E2-induced increases in uterine wet weight and TK activity by 29% and 39%, respectively. Treatment with TJ-25 also enhanced LH-RH-induced increases in plasma LH and FSH levels 1.2- and 2.5-fold, respectively, as compared with controls. The results obtained in the present study indicate that TJ-25 may act as a LH-RH antagonist and/or as a weak anti-estrogen.